Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
โ
of holders' portfolios
13F filers
0
institutions
52-week range
$37.06 โ $48.64
0% from low
Exchange
OTC Link
OS
COSMOS PHARM CORP ORD
No one on the platform currently holds CSMYF.
No tracked institution reports a position in CSMYF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2027-05-28 | $42.0000 | |
| 2026-11-30 | $42.0000 | |
| 2026-05-29 | $44.5000 | 2026-08-10 |
| 2025-11-28 | $37.5000 | 2026-02-12 |
| 2025-05-30 | $37.5000 | 2025-08-04 |
| 2024-11-29 | $32.5000 | 2025-02-12 |
| 2024-05-31 | $60.0000 | 2024-08-01 |
| 2023-11-29 | $60.0000 | 2024-02-13 |
| Execution date | Ratio |
|---|---|
| 2024-08-29 |
No one on the platform has traded CSMYF yet.
| 2-for-1 |
| 2020-05-28 | 2-for-1 |
No recent Form 4 filings on EDGAR โ either no insider transactions reported recently or this isn't a SEC-registered issuer.
$CSMYF Little bit of a bounce in intellia etc. just under $14 now $NTLA cosmo pharmaceuticals announced their quarterly results. The stock is down significantly today. Iโd look to purchase shares (buy and hold) in the next month or two before spring 12 month safety data is released on what I believe will be a (mega) blockbuster topical drug for male pattern hair loss. Stock had almost doubled after phase 3 results so looks like a good time to buy. Going to see where my cash is at then *will have to enable international trading - this is easy to do on your regular accounts, not in retirement
View on StockTwits โ$PBLA $CSMYF $AMC $GROM going to caca land let go ๐ค๐ค๐ค๐ค๐ค
View on StockTwits โRecent $TICKER stream from stocktwits.com โ refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $1.19T | +8.2% | $405.19 | $390.35โ$410.49 | 0.1ร | 1 |
| 2028 | $1.28T | +7.6% | $430.22 | $414.46โ$435.84 | 0.1ร | 1 |
| 2029 | $1.37T | +7.0% | $455.03 | $438.36โ$460.98 | 0.1ร | 1 |
| 2030 | $1.47T | +7.5% | $543.43 | $523.52โ$550.54 | 0.1ร | 1 |
Forward consensus ยท growth is YoY vs the prior fiscal-year estimate ยท Fwd P/E at the current price ยท source: Financial Modeling Prep
Beat consensus in 4 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-07-13 | $0.74 | $0.74 | -0.1% |
| 2026-04-13 | $0.65 | $0.66 | +1.6% |
| 2026-01-13 | $0.54 | $0.52 | -2.8% |
| 2025-10-14 | $0.76 | $0.70 | -8.0% |
| 2025-07-10 | $0.78 | $0.76 | -2.8% |
| 2025-04-14 | $0.51 | $0.66 | +30.8% |
| 2025-01-10 | $0.43 | $0.53 | +23.8% |
| 2024-10-11 | $0.61 |
| $0.70 |
| +15.8% |
| $3.8B |
| โ |
| GEDSFGedeon Richter PLC | $24.85 | +0.00% | $4.5B | โ |
| GNGBFGetinge AB (publ) | $22.49 | +0.00% | $5.7B | โ |
Source: Financial Modeling Prep ยท peers by sector/industry